Production & Manufacturing
BioPharma
Precision Medicine Manufacturing: From Large-Scale to Patient-Centric Production
The pharmaceutical industry is experiencing a fundamental shift away from the traditional “blockbuster drug” model toward increasingly sophisticated precision medicine manufacturing strategies that prioritize individual...
BioPharma
AI-Enabled Supply Chain Resilience in Pharmaceutical Manufacturing
Pharmaceutical supply chains are fundamentally evolving as global disruptions, regulatory demands, and patient expectations converge to redefine how drugs reach the market. In today’s environment,...
News
Eli Lilly Commits $1.2bn to Modernize Puerto Rico Manufacturing
Governor Jenniffer A. González Colón, along with Sebastián Negrón Reichard, the Economic Development and Commerce Secretary, has announced that Eli Lilly and Company, also known...
BioPharma
Investments in the U.S. of Over $70bn Announced by Merck
It is well to be noted that in 2025, a minimum of 14 major pharmaceutical companies across the world went ahead and announced plans to...
BioPharma
LTS Grows U.S. Footprint by Buying CDMO Renaissance Lakewood
As the U.S. production investments continue to roll in 2025, LTS Lohmann, the German pharmaceutical technology specialist, is joining the table with a deal to...
Business & Industry
AstraZeneca Plant Expansion to Double Production of Lokelma
AstraZeneca has gone on to announce a newly expanded manufacturing facility located in Coppell, Texas, U.S., which is going to double production of Lokelma for the...
BioPharma
Recipharm supports landmark trial of next generation pneumococcal vaccine developed by ImmBio and iiCON
Recipharm delivers cGMP manufacture of PnuBioVax® enabling progression to phase 2 clinical trials in Malawi.
Demonstrates Recipharm’s agility and flexibility, completing full tech transfer,...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.